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Minute virus of mice NS1, an 83-kDa mainly nuclear phosphoprotein, is the only viral nonstructural protein required in all
cell types and it is involved in multiple processes necessary for virus propagation. The diversity of functions assigned to NS1,
together with the variation of its complex phosphorylation pattern during infection, suggested that the various activities of
NS1 could be regulated by distinct phosphorylation events. So far, it has been demonstrated that NS1 replicative functions,
in particular, DNA-unwinding activities, are regulated by protein kinase C (PKC), as exemplified by the modulation of NS1
helicase activity by PKCl phosphorylation. In order to determine further impact of phosphorylation on NS1 functions,
including the induction of cytopathic effects, a mutational approach was pursued in order to produce NS1 variants harboring
amino acid substitutions at candidate PKC target residues. Besides the determination of two additional in vivo phosphory-
lation sites in NS1, this mutagenesis allowed the segregation of distinct NS1 functions from one another, generating NS1
variants with a distinct activity profile. Thus, we obtained NS1 mutants that were fully proficient for trans activation of the viral
P38 promoter, while being impaired in their replicative functions. Moreover, the alterations of specific PKC phosphorylation
sites gave rise to NS1 polypeptides that exerted reduced cytotoxicity, leading to sustained gene expression, while keeping
functions necessary for progeny virus production, i.e., viral DNA replication and activation of the capsid gene promoter.
These data suggested that in the course of a viral infection, NS1 may undergo a shift from productive to cytotoxic functions
as a result of a phosphorylation-dependent regulation. © 2000 Academic PressKey Words: parvovirus MVM; nonstructural protein NS1; PKC phosphorylation sites; site-directed mutagenesis; replicative
functions; cytopathic effects.
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1INTRODUCTION
Parvoviruses are small nonenveloped icosahedral par-
ticles with a single-strand linear DNA as a genome.
Propagation of these viruses is strongly dependent on
the proliferation and differentiation states of their host
cells, in which a productive infection usually leads to
cytolysis. These requirements can be fulfilled upon neo-
plastic transformation as apparent from the preferential
multiplication of parvoviruses in some tumor cells (on-
cotropism) and their consequent oncolytic effect (for a
review see Rommelaere and Cornelis, 1991). The 5.1-kb
genome of the type species minute virus of mice (MVM)
codes for two structural (VP) and at least four nonstruc-
tural (NS) proteins (for review see Cotmore and Tatter-
sall, 1987). From the nonstructural proteins, only the
83-kDa NS1 is required for progeny virus production in
all cell types (Naeger et al., 1990). This multifunctional,
mainly nuclear phosphoprotein is involved in many steps
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Applied Tumor Virology, Abteilung F0100,
NSERM U375, Deutsches Krebsforschungszentrum, Im Neuenheimerp
eld 242, D-69120 Heidelberg, Germany. Fax: (49) 6221 424962. E-mail:
pf.nuesch@dkfz-heidelberg.de.
151of the virus life cycle. In addition to having activities
directly related to the production of viral components,
e.g., initiation of viral DNA replication (Tullis et al., 1988;
otmore et al., 1992, 1993) and induction of the capsid
ene promoter (Rhode and Richard, 1987), NS1 exerts
ytotoxic effects on the host cell (Caillet-Fauquet et al.,
990). Furthermore, NS1 is associated with cellular ul-
rastructural changes, as exemplified by the accumula-
ion of the viral product in recently described nuclear
odies (designated PAR) that are specifically induced by
arvovirus infection and are sites of viral DNA replication
Cziepluch et al., 2000).
The diversity of NS1 functions necessary for virus
propagation suggested that this viral polypeptide might
be regulated by posttranslational modifications, such as
phosphorylation. Indeed NS1 was found to become
phosphorylated on serine and threonine residues during
an MVM infection, undergoing changes in its phosphor-
ylation pattern concomitantly with the progress of a syn-
chronized infection (Corbau et al., 1999). The altered
iochemical profile of native NS1P expressed from re-
combinant vaccinia viruses in HeLa cells, compared to
its dephosphorylated (NS1O) counterpart (Nu¨esch et al.,
998a), further argued for the fact that NS1 may be
rimed for distinct functions by differential phosphoryla-
0042-6822/00 $35.00
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152 CORBAU ET AL.tion altering its enzymatic activities. In particular, using a
kinase-free in vitro replication system, NS1-dependent
nitiation of rolling-circle replication was shown to be
ependent upon protein kinase C (PKC) phosphorylation
Nu¨esch et al., 1998b). This defect of dephosphorylated
NS1 for DNA replication could be assigned, at least in
part, to regulation of NS1 DNA-unwinding activities by
atypical PKCl (Dettwiler et al., 1999).
These findings prompted us to determine the impact of
phosphorylation on additional NS1 functions necessary
for virus propagation, besides DNA replication, and to
evaluate more particularly whether cellular alterations
caused by NS1 are the result of a phosphorylation-
regulated process. To this end, we performed site-di-
rected mutagenesis at candidate phosphorylation sites
in NS1, changing target serine or threonine residues to
alanine residues. Mutant NS1 polypeptides were then
characterized in comparison with the wild-type protein
for their nuclear translocation, oligomerization, and func-
tioning in viral DNA replication, trans activation of the
capsid gene promoter (P38), and induction of cytopathic
effects. In addition, we tested whether the putative phos-
phorylation sites under investigation indeed served as
targets for cellular kinases in vivo upon NS1 expression
from recombinant vaccinia viruses, taking advantage of
the fact that the phosphorylation pattern of NS1 pro-
duced under these conditions is very similar to that
observed during the replicative phase of a genuine MVM
infection (Corbau et al., 1999). The present investigation
allowed us to identify two in vivo phosphorylation sites,
namely, T403 and T435, that are likely to consist of NS1
regulatory elements during the replicative phase of a
virus infection, besides the previously described PKCl
site S473 (Dettwiler et al., 1999). Furthermore, the mu-
agenesis at conserved PKC phosphorylation sites al-
owed the segregation of distinct NS1 activities from one
nother. Thus, we generated mutant forms of NS1, which
re deficient for replication, but still able to trans activate
the P38 promoter. Furthermore, some NS1 mutants mim-
icking partially dephosphorylated polypeptides were
found to be endowed with a reduced cytotoxicity, result-
ing in their sustained expression over an extended pe-
riod of time. This argues for the occurrence of additional
regulatory elements that are activated late in infection, at
times when alterations within the phosphopeptide pat-
tern become apparent (Corbau et al., 1999).
RESULTS
Generation of NS1 mutants harboring amino acid
substitutions for putative phosphorylation sites
Previous investigations have shown that NS1 replica-
tive functions are regulated by members of the PKC
family (Nu¨esch et al., 1998b; Dettwiler et al., 1999). In
order to determine whether an additional NS1 function(s)
necessary for virus propagation might be regulated byphosphorylation, we carried out mutational analyses of
NS1, targeting a number of candidate phosphorylation
sites. Serine/threonine residues were changed to ala-
nine, and the resulting NS1 variants were tested for their
in vivo phosphorylation as well as functional profile.
Previous in vivo analyses have shown that the majority of
phosphorylation events occurring during the productive
phase of an MVM infection are confined to an 18-kDa
fragment spanning NS1 residues M314 to M483 (Corbau
et al., 1999; see Fig. 1A). This was confirmed by tryptic
phosphopeptide analyses of metabolically 32P-labeled
NS1 deletion mutants expressed by recombinant vac-
cinia viruses in HeLa cells. This is illustrated in Fig. 1B,
showing that NS1-Hel, a truncated NS1 polypeptide ex-
tending from M256 to the very C-terminus (Fig. 1A),
contained the majority of NS1 tryptic phosphopeptides
(Fig. 1B, panels a, c, and d). It should be stated that
phospho-amino acid analyses of individual NS1 peptides
have indicated that both serine and (to a lesser extent)
threonine residues became phosphorylated during an
MVM infection (Corbau et al., 1999; Fig. 1B, panel b).
Altogether, these data led us to focus our mutagenesis
on NS1 residues S283, T363, T403, T435, and T463,
which are all included in a consensus PKC phosphory-
lation site and were changed individually to an inert
alanine in order to mimic partially dephosphorylated
NS1. In addition to these candidates, two NS1 mutants
were included in the present work: T394A, harboring an
amino acid substitution at a highly conserved PKA con-
sensus site, and S473A, previously shown to be a PKCl
phosphorylation site mutant (Dettwiler et al., 1999). For
functional analyses, all mutants were expressed from
various constructs, including pTHisNS1x, which allows
S1 to be produced by means of recombinant vaccinia
iruses and to be further purified by Ni-affinity chroma-
ography due to an N-terminal (His)6 tag (Nu¨esch et al.,
1992, 1995). As shown in Fig. 1C, all the above-men-
tioned NS1 derivatives could be expressed and purified
in extensive amounts, arguing for the stability of the
mutant polypeptides. Interestingly, NS1:T403A (carrying
an amino acid substitution within the nucleotide-binding
domain) consistently resolved into two distinct species
after SDS–PAGE. Both species were produced from in-
dividual vaccinia virus isolates and became phosphory-
lated in vivo (data not shown), suggesting that the
polypeptide chain may adopt alternative conformations
during translation.
NS1 functions involved in virus propagation
Nuclear translocation. It was previously shown that
wild-type NS1 is found mainly in the nuclear compart-
ment of the cell, with a minor, yet significant, proportion
(30%) of the protein being present in the cytoplasm of
virus-infected host cells (Cotmore and Tattersall, 1986).
This distribution was found to be altered for some NS1
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153MUTAGENESIS OF MVM NS1 PKC PHOSPHORYLATION SITESvariants, the naturally occurring 65-kDa NS1* and the
C-terminal truncation mutant NS1dlC67. Thus, both
polypeptides were found to be almost entirely (.95%)
nuclear (Cotmore and Tattersall, 1986; Nu¨esch and Tat-
tersall, 1993), while the deletion mutant NS1dl158, lack-
ing a nuclear localization signal (NLS), and NS1sbDYKD,
containing point mutations in the triple-lysine motif of the
NLS, remained cytoplasmic (Nu¨esch and Tattersall,
1993). In order to investigate whether the cellular distri-
bution of NS1 may be regulated by phosphorylation, as
shown for SV40 large T antigen (LT) with which NS1
shares a number of similarities (Astell et al., 1987), we
analyzed the NS1 phosphorylation site mutants for their
ability to translocate to the nuclear compartment of host
cells. As previously described (Nu¨esch and Tattersall,
1993), A9 cells were coinfected with recombinant vac-
cinia viruses vTF7-3 (providing the bacteriophage T7
polymerase) and vHisNS1x (carrying the NS1 gene under
ontrol of the T7 promoter) to allow expression of NS1
roteins, fixed 5 h postinfection, and processed for the
ocalization of NS1 by indirect immunofluorescence us-
ng aNS1c antiserum (Cotmore and Tattersall, 1988). As
shown in Fig. 2, all the phosphorylation site mutants
tested gave rise to intense nuclear staining, indicating
that they were not impaired in nuclear translocation. In
contrast, the NLS2 mutant NS1dl158, used as a control,
as found in the cytoplasm. Thus, none of the phosphor-
lation sites under investigation appeared to be involved
n the regulation of NS1 nuclear migration.
Oligomerization. For several of its functions, NS1 is
hought to act as a multimer rather than a monomeric
olypeptide, as exemplified for virus propagation and
ntrinsic helicase function (Pujol et al., 1997). Such NS1:
S1 interactions, as revealed in vivo through the ability
f wild-type NS1 to cotransport mutant derivatives lack-
FIG. 1. Site-directed mutagenesis of MVM NS1. (A) Schematic rep-
resentation of the domain structure of NS1. The NS1 residues that
constitute putative targets for PKA (underlined) or PKC (other) and were
chosen for mutagenesis are indicated with their amino acid numbers.
Residue 278 (in parentheses) was changed in an oligomerization mu-
tant used as a control. The 18-kDa CNBr cleavage fragment (aa 314–
483), harboring major phosphorylation sites after MVM infection (Cor-
bau et al., 1999), is depicted as a shaded box; the common N-terminus
of NS1 and NS2 is depicted as a dotted box. The truncated NS1-Hel
polypeptide (aa 256–672) is aligned at the bottom of the scheme. (B)
Analysis of the phosphorylation pattern of NS1. (a, b) Schematic rep-
resentations of a typical tryptic phosphopeptide map of MVM NS1
(Corbau et al., 1999) during the replicative phase of infection (a) and
determination of the corresponding phospho-amino acids (b). (c, d)
Tryptic phosphopeptide patterns of metabolically 32P-labeled wild-type
NS1 (c) and NS1-Hel (d) expressed from recombinant vaccinia virus. (C)
Analysis of wild-type and mutant His-tagged NS1 proteins expressed
from vaccinia viruses after one-step purification of Ni21-NTA agarose,
using 10% SDS–PAGE and Coomassie blue staining. The sizes of
molecular weight markers are given on the left. The position of His-
tagged (wild-type) NS1 protein and the aberrant migration of the major
NS1:T403A species are indicated on the right.
v
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154 CORBAU ET AL.ing an NLS into the nuclear compartment, proved to
depend on an intact ATP-binding site (Nu¨esch and Tat-
FIG. 2. Intracellular distribution of wild-type and mutant NS1 exp
recombinant vaccinia viruses 5 h postinfection using aNS1c antiserum
TF7-3 1 vNS1inN10dl158 (cytoplasmic control); (d) vTF7-3 1 vHisN
vTF7-3 1 vHisNS1:T394A; (h) vTF7-3 1 vHisNS1:T403A; (i) vTF7-3 1tersall, 1993). This dependency on the interaction with a
cofactor indicated that NS1 oligomerization consists of aregulated rather than a constitutive NS1 property. Thus, it
was of interest to analyze the NS1 phosphorylation mu-
in A9 cells. Immunofluorescence analyses of NS1 expressed from
ection. (a) vTF7-3 alone (negative control); (b) vTF7-3 1 vHisNS1wt; (c)
8A; (e) vTF7-3 1 vHisNS1:S283A; (f) vTF7-3 1 vHisNS1:T363A; (g)
1:T435A; (k) vTF7-3 1 vHisNS1:T463A; (l) vTF7-3 1 vHisNS1:S473A.ressed
for det
S1:T27tants under investigation for their ability to self-associate.
Interactions between NS1 molecules were detected by
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155MUTAGENESIS OF MVM NS1 PKC PHOSPHORYLATION SITESmeans of the above-mentioned cotransport assay using
the cytoplasmic NS1:inN10dl158, a FLAG epitope-carry-
ing deletion mutant as a prey. A9 cells were coinfected
with the recombinant vaccinia viruses vTF7-3, vNS1:
inN10dl158, and vHisNS1x. As depicted in Fig. 3A, the
intracellular distribution of the individual NS1 proteins
was determined at 11 h postinfection by double-immu-
nofluorescence using the mouse monoclonal antibody
aM2 (recognizing specifically the FLAG epitope fused
with the N-terminus of the cytoplasmic variant
inN10dl158), together with the rabbit aNLS antiserum
(raised against amino acids 101 to 223 of NS1, a region
that is deleted in dl158). The reliability of the assay was
tested using wild-type NS1 and mutant K405M as posi-
tive and negative controls for carrier proteins, respec-
tively (Nu¨esch and Tattersall, 1993). Coexpressed wild-
type NS1 and inN10dl158 were both found in the nuclear
compartment of infected cells, whereas NS1:K405M (by
itself mainly nuclear) was unable to direct the cytoplas-
mic deletion mutant into the nucleus (Fig. 3B, panels A/a
to D/d). As an additional negative control, the HisNS1:
T278A mutant was constructed to produce an NS1 pro-
tein that harbors an amino acid substitution within the
NS1:NS1 interaction motif 261-VETTVT(X9)IQT-278, pre-
venting this motif from associating with NS1 in a peptide
ELISA (Pujol et al., 1997). Like K405M, T278A failed to
alter the intracellular distribution of inN10dl158, confirm-
ing the role of NS1:NS1 interaction in the nuclear trans-
location of the latter mutant in the presence of wild-type
NS1 (Fig. 3B, panels E/e). As exemplified for the replica-
tion-deficient NS1 variants (Fig. 3B, panels F/f to K/k) all
phosphorylation mutants proved able not only to migrate
to the nucleus on their own (Fig. 2), but also to induce
nuclear translocation of the coexpressed inN10dl158,
demonstrating that they retained the capacity for NS1:
NS1 interaction. Thus none of the putative regulatory
elements under investigation appeared to be involved in
the modulation of NS1 self-association.
DNA replication. Using an in vitro replication system
devoid of endogenous kinases, it has been shown that
NS1 replicative functions are dependent on phosphory-
lation by members of the PKC family (Nu¨esch et al.,
1998b). Therefore, it was of interest to determine the
impact of mutagenesis at putative target PKC phosphor-
ylation sites on the capacity of NS1 for driving viral DNA
replication. To investigate this NS1 function, we per-
formed in vitro assays, analyzing NS1-dependent repli-
cation and resolution reactions of MVM origins from
concatameric viral DNA. Plasmid clones of head-to-head
dimer-bridge (pLEB711) and tail-to-tail tetramer-bridge
(pREB1412) fragments were used as substrates in stan-
dard HeLa replication extracts, supplemented with puri-
fied wild-type or mutant NS1 proteins and [a-32P]dATP as
escribed (Cotmore et al., 1992, 1993). The 32P-labeled,
S1-attached replication products were immunoprecipi-
ated using aNSN antiserum and digested with the re-
c
istriction endonuclease ScaI. The ScaI cleaved reaction
products were then fractionated by centrifugation into
NS1-attached and NS1-free DNA products, which were
then analyzed individually by agarose gel electrophore-
sis. As illustrated in Fig. 4, mutants T363A, T394A, T403A,
T435A, and S473A were unable to resolve and replicate
plasmids containing either the left-end or the right-end
bridge, indicating that these residues are essential for
the replication activity of NS1. Thus, these putative PKC
phosphorylation sites could indeed consist of regulatory
elements. In contrast, S283A and T463A retained all the
NS1 activities that are necessary to carry out replication
and resolution reactions initiated at both left- and right-
end origins of the viral genome, albeit to a significantly
reduced level compared to wild-type NS1, suggesting
that phosphorylation of these residues is not absolutely
required for the replicative functions of the polypeptide.
Thus, phosphorylation of S283 and T463 most likely does
not regulate initiation of viral DNA replication.
P38 trans activation. Phosphorylation of NS1 was
shown to serve as a means to regulate different bio-
chemical activities of the polypeptide, such as its capac-
ity for site-specific DNA binding (Nu¨esch et al., 1998a).
Besides its key role in viral DNA replication, NS1 was
found to be a strong trans activator of the viral P38
promoter driving the capsid genes (Rhode and Richard,
1987). Transcriptional and replicative functions have dis-
tinct requirements for the biochemical properties of the
effector protein, including DNA binding. This prompted
us to investigate which NS1 variant might be primed for
either transcriptional or replicative functions depending
on its state of phosphorylation. To this end, we analyzed
the NS1 phosphorylation mutants for their ability to acti-
vate the capsid gene promoter in transient transfection
assays. All mutants were expressed from pRSV-NS con-
structs (Spegelaere et al., 1994) in A9 cells cotransfected
with the reporter plasmid pP38-Luc (Vanacker et al.,
1996). Wild-type NS1 and mutant K405M, which has been
reported to be deficient in P38 trans activation (Nu¨esch
et al., 1992), were used as positive and negative controls,
respectively. Cells were harvested 48 h posttransfection
and extracts were measured for luciferase activity. Data
from multiple transfection experiments using various
concentrations of NS1 expression vector are summa-
rized in Fig. 5 and are expressed as a percentage of the
value measured with NS1wt, after subtraction of the basal
ctivity of the reporter plasmid alone. While substitutions
or S473 (as previously reported by Dettwiler et al., 1999)
nd T463 had little influence on NS1-induced P38 trans
ctivation, T363A and T403A were almost entirely nega-
ive for these functions. Intermediate phenotypes were
bserved with the other mutants that stimulated P38 up
o 45% (T435A) or 20% (S283A, T394A) of wild-type activ-
ty. The trans activation capacity of T435A and S473A
ontrasts with their incompetence for replication, indicat-
ng that both functions of NS1 can be segregated from
156 CORBAU ET AL.
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157MUTAGENESIS OF MVM NS1 PKC PHOSPHORYLATION SITESeach other by distinct mutations that mimic a partially
dephosphorylated polypeptide. It must be mentioned,
however, that some of the reported effects could result
from structural/conformational abnormalities caused by
amino acid substitution, rather than from the lack of
phosphorylation of the target site.
Phosphorylation of candidate NS1 residues. In order to
substantiate the relevance of phosphorylation for the reg-
ulation of NS1 functions involved in virus amplification, we
determined whether the NS1 residues under investigation
were indeed targets for phosphorylation in vivo. The wild-
type and mutant forms of NS1 proteins produced by vac-
cinia virus infection were used to perform comparative
tryptic phosphopeptide analyses, taking advantage of the
fact that the phosphorylation pattern of NS1 expressed by
recombinant vaccinia viruses closely mimics the pattern
observed during the productive phase of an MVM infection
(Corbau et al., 1999). HeLa cells were coinfected with
TF7-3 and vHisNS1x, and metabolically
32P-labeled NS1
as analyzed as previously described (Corbau et al., 1999).
hree of the functionally impaired NS1 mutants described
bove, T403A (Fig. 6, middle), T435A (Fig. 6, bottom), and
473A (Dettwiler et al., 1999), could indeed be distin-
uished from the wild-type protein by the absence of one
ajor phosphopeptide each, arguing for the role of phos-
horylation at the respective positions in the regulation of
he viral product. In contrast, all phosphopeptides previ-
usly determined for wild-type NS1 were also detected
hen analyzing the other mutants, as exemplified for T363A
Fig. 6, top), suggesting that their functional alterations re-
ulted from the amino acid substitution per se rather than
heir incomplete phosphorylation. It should be stated, how-
ver, that mutants S283A, T363A, T394A, and/or T463A
ight be deficient in phosphorylation and consequent reg-
lation during the early or late phases of infection, which
ave been shown to differ regarding the NS1 phosphory-
ation pattern from the replicative phase as well as the NS1
xpressed from vaccinia viruses (Corbau et al., 1999).
S1-induced cell alterations
In the course of an MVM infection, the NS1 phosphor-
lation pattern has been shown to change significantly
FIG. 3. Oligomerization of NS1 proteins. The ability of wild-type and m
transport the cytoplasmic variant NS1:inN10dl158 into the nucleus. (A) Sch
NS1 is shown on the top, with the location of the nuclear localization sig
TP-binding site. The NS1:inN10dl158 mutant (cyt) is impaired for nucl
ranslocation-competent NS1 polypeptide (nuc) serving as a carrier. The a
aNS1NLS are cross-hatched in the respective drawings and were used
ouble-immunofluorescence analysis of A9 cells coinfected with vTF7-3,
Mouse monoclonal M2 antibodies were detected with FITC-conjugated
polyclonal antibodies were revealed by means of Texas red-conjugated g
both NS1:inN10dl158 and NS1x are indicated with arrowheads. (A/a) vTF7-3
vHisNS1wt (positive control); (D/d) vTF7-3 1 NS1:inN10dl158 1 vHisNS1:K
vTF7-3 1 NS1:inN10dl158 1 vHisNS1:T363A; (G/g) vTF7-3 1 NS1:inN10dl158 1
TF7-3 1 NS1:inN10dl158 1 vHisNS1:T435A; (L/l) vTF7-3 1 NS1:inN10dl158 1 voward the end of the virus cycle when cytopathic effects
ecome apparent (Corbau et al., 1999). This raises the
ossibility that phosphorylation may also regulate the
apacity of NS1 to induce cellular alterations. To inves-
igate such a possibility, we compared wild-type NS1
ith the phosphorylation mutants for their respective
ytopathic effects. This was determined by means of
ransient transfection experiments using an effector/re-
orter construct designed to keep the genuine viral en-
ironment as close as possible. As depicted in Fig. 7A,
S1 was expressed from its genuine parvoviral cassette
irected by the early promoter P4. To identify transiently
ransfected cells, the EGFP (enhanced green fluorescent
rotein)-encoding gene was coexpressed from the same
onstruct under the control of the early promoter of either
ytomegalovirus (in constructs producing NS1wt, G404V,
and T403A) or MVM P4- (in constructs producing no NS1
or NS1wt, T278A, S283A, T363A, T394A, T435A, T463A,
and S473A). This type of effector/reporter construct al-
lows NS1-expressing cells to be identified after transient
transfection and their analysis for cytopathic effects in
the absence of drugs (used to isolate stable transfec-
tants or to induce conditional promoters) and without the
need for cell fixation (thereby producing artifacts due to
cell dehydration). This assay does not rely on the ampli-
fication of the construct or the presence of NS2 and is
therefore suitable for comparing NS1 mutants for their
intrinsic toxicity irrespective of their competence to pro-
duce progeny virus particles. In fact, all constructs under
investigation were unable to replicate in A9 cells, most
likely due to the absence of full-length NS2 (data not
shown). Thus, A9 cells grown on spot slides were trans-
fected with the various NS1/GFP constructs using lipo-
fectamine and examined by fluorescence microscopy in
daily intervals up to day 7 posttransfection. These time-
course experiments are illustrated in Fig. 7B, showing
representative cell populations. In the absence of NS1,
no significant morphological changes could be detected
in A9 cells expressing EGFP over a 7-day period (Fig. 7B,
row 1). In contrast, in the presence of wild-type NS1
(rows 2 and 5), cells started to round up from day 2
posttransfection onward, with the numbers of affected
S1 polypeptides to self-associate was measured through their ability to
representation of the constructs used in the cotransport assay. Full-length
S), a peptide involved in NS1:NS1 interaction (Pujol et al., 1997), and the
slocation by itself unless cotransported through its association with a
FLAG epitope recognized by aM2 and the NS1 epitope used to produce
separate detection of the cyt mutant and its potential nuc carrier. (B)
nN10dl158, and vHisNS1x at 11 h postinfection using aM2 and aNS1NLS.
nti-mouse IgGs (panels marked with uppercase letters); rabbit NS1NLS
i-rabbit IgGs (panels marked with lowercase letters). Cells coexpressing
sNS1wt; (B/b) vTF7-3 1 NS1:inN10dl158; (C/c) vTF7-3 1 NS1:inN10dl158 1
negative control); (E/e) vTF7-3 1 NS1:inN10dl158 1 vHisNS1:T278A; (F/f)utant N
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vHisNS1:T394A; (H/h) vTF7-3 1 NS1:inN10dl158 1 vHisNS1:T403A; (I/i)
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158 CORBAU ET AL.cells increasing with time until most of the cultures
showed this phenotype (usually after day 4). It has pre-
viously been reported that the nucleotide-binding site
mutant NS1-G404V (pULB3241) is nontoxic in a colony
formation assay measuring the ability of NS1 to inhibit
stable transformation of human cells by cotransfection
with a neomycin expression cassette (Legendre and
Rommelaere, 1992). In order to determine whether our
data correlated with this toxicity assay, the same mutant
was included in our analyses and indeed proved incom-
FIG. 4. Initiation of replication and resolution of MVM origins by wild-
or their activity in replication and resolution assays, using standard
pREB1412) origins in the presence of 32P-labeled nucleotides. Reac
ubdivided into NS1-attached (pellet, P) and NS1-free (supernatant, S)
nalyzed by 0.8% agarose gel electrophoresis and autoradiography.
lasmid; TC and GAA, plasmid parts containing the TC and GAA arms
caI. (B) Replication and resolution reactions using pREB1412 as a subs
fter resolution and cleavage with ScaI.petent for the induction of cell rounding-up (row 3). An
additional negative control was provided by the oli-gomerization mutant T278A, which was found to be un-
able to cause morphological alterations of the host cell,
arguing for the dependence of these disturbances on
NS1 oligomerization. We then analyzed the impact of
alanine substitutions for various (putative) phosphoryla-
tion sites of NS1 on the occurrence of cytopathic effects,
in a first attempt to correlate these changes with a
possible phosphorylation-dependent regulation and dis-
tinct functions of NS1. As shown in Fig. 7B (rows 6, 8, and
9), some NS1 mutants (S283A, T394A, and T403A) were
d mutant NS1. Purified wild-type and mutant NS1 proteins were tested
extracts supplemented with cloned left-end (pLEB711) or right-end
ducts were immunoprecipitated with aNSN, cleaved with ScaI, and
ns by centrifugation. The deproteinized cleavage products were then
lication reactions using pLEB711 as a substrate. L, linearized input
dimer bridge, respectively, after resolution by NS1 and cleavage with
., linearized input plasmid; A and B, large and small parts of pREB1412type an
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of theable to induce A9 cells to round up and, like the wild-type
protein, started to detach as early as 2 days posttrans-
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159MUTAGENESIS OF MVM NS1 PKC PHOSPHORYLATION SITESfection. This process was even accelerated in S283A-
expressing cells, indicating that NS1 is endowed with a
greater cytotoxic potential than that exerted by the wild-type
protein in normal circumstances, possibly due to its down-
modulation by distinct phosphorylation events. It is also
worth noting that the capacity of NS1 for the altering of the
cell morphology could be segregated from its replication
and trans activation functions, as exemplified by T403A,
uggesting that the latter activities are not required for at
east some facets of NS1 cytotoxicity. In contrast, T435A,
463A, and S473 were unable to induce cell rounding-up
fficiently (Fig. 7B, rows 10–12) and did not appear to pre-
ent transfected cells from growing, as suggested by the
ncrease in the fraction of fluorescent cells with time (data
ot shown). Double-fluorescence staining of transfected
ells was performed to test whether expression of the
nontoxic” NS1 phosphorylation variants (T435A, T463A,
nd S473A, respectively) indeed persisted over extended
eriods of time. Seven days posttransfection, cultures were
ixed, and GFP-positive cells were tested for the expression
f NS1 by indirect immunofluorescence using aNS1c, an
ntiserum raised against the 16 C-terminal amino acids of
S1 (Cotmore and Tattersall, 1988). As illustrated in Fig. 8,
he majority of GFP-positive cells transfected with P4-NS1:
T435A, T463A, or S473A)-P4-GFP stained positive for NS1
s well, demonstrating that the maintenance of these cells
n culture resulted from the lack of toxicity, rather than the
ack of expression or rapid degradation of the mutant forms
f NS1. Thus, several NS1 phosphorylation site mutants,
FIG. 5. Trans activation of the capsid gene promoter by wild-typ
polypeptides to trans activate the P38 promoter was measured after c
reporter and effector plasmids, respectively. At 48 h posttransfection, c
are average values with standard deviation bars from multiple indepen
by pRSV-NSwt, after subtraction of the background value measured in th
etermined by Dettwiler et al. (1999).ne being active for both replicative and transcriptional
unctions (T463A) together with two mutants competent forrans activation (T435A and S473A) that proved to be un-
erphosphorylated in vivo, failed to show any cytopathic
activity within the time period tested. Besides confirming
that NS1 toxicity is not only a by-product of the replicative
and trans activating properties of the protein, these data
confirm the possibility that distinct phosphorylation events
prime NS1 to perform functions involved in virus multiplica-
tion and cell alterations, respectively. Further investigations,
however, will be necessary to determine whether one or
several of these residues are indeed phosphorylated in vivo
late in infection. It is also worth noting that the T363A
mutant exhibited a phenotype intermediate between that of
wild-type NS1 and that of the nontoxic mutants. Indeed
T363A-expressing cells did not round-up but underwent
unique morphological changes consisting of their spread-
ing out and forming “axon-like” structures, some of which
exceeded twice the length of a normal cell. Such changes
are also observed upon MVM infection of A9 cells (data not
shown) and may therefore represent a physiological out-
come of the viral life cycle.
DISCUSSION
The changes within the phosphorylation pattern of
MVM NS1 in the course of a viral infection (Corbau et al.,
1999) argue for the regulation of this multifunctional
polypeptide by phosphorylation. This possibility is sup-
ported by the fact that NS1 needs to be phosphorylated
by PKC in order to exert its replicative functions in vitro
mutant NS1 polypeptides. The ability of wild-type and mutant NS1
ction of A9 cells with pP38-Luc and various amounts of pRSV-NSx as
re harvested and analyzed for luciferase activity. The data presented
xperiments and are expressed as percentages of the activity induced
nce of effector plasmid. * The value obtained for S473A was previouslye and
otransfe
ells we
dent e(Nu¨esch et al., 1998b; Dettwiler et al., 1999). It is still
unknown, however, whether other NS1 functions, be-
160 CORBAU ET AL.sides replication, are regulated in a positive or negative
way through posttranslational modifications. If this is
indeed the case, these modifications may prime the
multifunctional NS1 protein for distinct tasks in the
course of a viral infection, in keeping with the altered
biochemical profile of dephosphorylated versus native
NS1 (Nu¨esch et al., 1998a). While still lacking direct
experimental evidence, this possibility is strongly sup-
ported by the present analyses of NS1 phosphorylation
site mutants for their functional profile as summarized in
Table 1 and further substantiated by analyses of these
mutants at the biochemical level (Nu¨esch et al., manu-
script in preparation). Indeed, some of the residues tar-
geted for mutagenesis were found to be phosphorylation
FIG. 6. In vivo determination of NS1 phosphorylation sites. NS1
phosphorylation sites were identified by comparing the phosphoryla-
tion patterns of wild-type and mutant NS1 proteins expressed from
recombinant vaccinia viruses in HeLa cells. NS1 polypeptides were
metabolically 32P-labeled, purified by immunoprecipitation with aSP8
followed by SDS–PAGE, and digested with trypsin. The tryptic phos-
phopeptides were then analyzed by two-dimensional thin-layer elec-
trophoresis/chromatography and revealed by autoradiography. Phos-
phopeptides that are missing in the mutant (compared to the wild type)
NS1 pattern are indicated with an arrow.sites in vivo. These mutants, which mimic partially de-
phosphorylated NS1, proved to be impaired in their re-spective replicative functions, while two of these were
still competent for trans activation. Nevertheless, some
limitations in the use of site-directed mutants for mim-
icking partially (de)phosphorylated NS1 must be recog-
nized, since structural modifications due to the amino
acid substitutions may modify the function of the protein
irrespective of its phosphorylation. Further investiga-
tions, using dominant-negative protein kinase mutants in
vivo, will be necessary to prove the involvement of these
phosphorylation sites in the regulation of NS1 activities.
In addition to mutants affecting the production of viral
components, replication and/or trans activation-compe-
tent mutants were generated, which were deficient in the
induction of cytopathic effects, providing a first indication
that at least some facets of NS1 toxicity may also be
subject to regulation through phosphorylation. Together
with our previous observations showing that NS1 under-
goes striking changes in its phosphorylation pattern dur-
ing the successive early, replicative, and late phases of
infection (Corbau et al., 1999), the present observations
FIG. 7. NS1-induced changes in host cell morphology. NS1 was
tested for its cytopathic effect after transfection of A9 cells with pP4-
NS1x-CMV-GFP or pP4-NS1x-P4-GFP, in comparison with pP4-GFP
used as a negative control. Successfully transfected cells were iden-
tified through their positive GFP fluorescence and monitored at daily
intervals. (A) Schematic representation of the individual constructs,
showing the indicator (EGFP) and effector (NS1) genes with their
respective promoters and 39 untranslated regions. P4, genuine MVM
NS-gene promoter; CMV, cytomegalovirus early promoter; 39UTR, gen-
uine MVM polyadenylation signal; poly(A), SV40 polyadenylation signal.
LO and RO, left- and right-end origins of MVM DNA replication, respec-
tively. The NS1 gene, the truncated NS2 coding body, and the GFP gene
are represented as hatched, dotted, and cross-hatched boxes, respec-
tively (B). Analysis of representative populations of GFP-expressing
cells at indicated times posttransfection. (1) pP4-GFP (negative control);
(2) pP4-NS1wt-CMV-GFP; (3) pP4-NS1:G404V-CMV-GFP; (4) pP4-NS1wt-
P4-GFP; (5) pP4-NS1:T278A-P4-GFP; (6) pP4-NS1:S283A-P4-GFP; (7)
pP4-NS1:T363A-P4-GFP; (8) pP4-NS1:T394A-P4-GFP; (9) pP4-NS1:
T403A-CMV-GFP; (10) pP4-NS1:T435A-P4-GFP; (11) pP4-NS1:T463A-
P4-GFP; (12) pP4-NS1:S473A-P4-GFP.
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timely coordinated regulation of NS1 activities.
Although in certain cell lines parvovirus H-1 infection
was shown to induce apoptosis (Rayet et al., 1998; Os-
hima et al., 1998; Ran et al., 1999), the general mecha-
isms of parvovirus cytotoxicity, eventually leading to the
ysis of productively infected cells as seen for the proto-
FIG. 8. Sustained expression of less cytopathic mutant forms of NS1
GFP. At 7 days posttransfection cultures were fixed, and GFP-fluoresce
NS1 by immunofluorescence using aNS1c antiserum and Texas red-cype strain MVMp in A9 cells, is still elusive. The NS1
rotein proved to be a major effector of parvovirus tox-icity (Caillet-Fauquet et al., 1990; Li and Rhode, 1990;
Mousset et al., 1994), and several NS1 activities are
candidates for the induction of cell disturbances (Leg-
endre and Rommelaere, 1992; Op De Beeck et al., 1995;
Op De Beeck and Caillet-Fauquet, 1997; Anouja et al.,
1997). Some of these activities might be necessary to
establish a productive infection and could occur already
lls were mock-treated and transfected with pP4-GFP or pP4-NS1x-P4-
s (identified in the FITC channel) were analyzed for the expression of
ed goat anti-rabbit IgGs.. A9 ceearly in infection, with a possible delayed effect on host
cell survival. Thus, NS1 was shown to trans regulate not
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163MUTAGENESIS OF MVM NS1 PKC PHOSPHORYLATION SITESonly viral but also cellular promoters (Rhode and Richard,
1987), which may contribute to the dysregulation of cel-
lular gene expression, as exemplified by the NS1-medi-
ated activation of specific genes (Vanacker et al., 1996)
and alteration of cellular kinase activity (Anouja et al.,
1997). Another by-product of NS1 replicative functions
may consist of the induction of nicks into chromosomal
DNA (Op De Beeck and Caillet-Fauquet, 1997) and cell
cycle arrest in late S-phase (Op De Beeck et al., 1995;
Op De Beeck and Caillet-Fauquet, 1997; Corbau et al.,
999). Yet the present data show that some mutant forms
f NS1 failed to induce morphological alterations of the
ost cell, while being fully competent for replicative and
rans activating functions, indicating that at least some
roperties of NS1 leading to cell lysis after infection may
e uncoupled from the replicative phase of the virus life
ycle and represent intrinsically toxic processes regu-
ated by phosphorylation. The latter processes may be
nduced late in infection in order to promote efficient
elease of progeny virus particles.
Cytotoxicity of NS1 was first demonstrated through the
apacity of the viral product for inhibiting cell colony
ormation (Caillet-Fauquet et al., 1990; Li and Rhode,
990), which could be assigned to cytocidal and/or cyto-
tatic effects. The initial occurrence of the latter effect is
upported by the observation of cell cycle arrest upon
VM infection (Op De Beeck et al., 1995; Corbau et al.,
1999). In addition, by analysis of cell lines stably trans-
fected with a conditional NS expression cassette, cells
TABLE 1
Effects of Mutagenesis at Conserved Phosphorylation Sites
Mutation
NS1 Propertya
Phosb Nucc Oligod Repe P38-TA f Toxg
Wild type 1 1 1 1 1
S283A No 1 1 1 6 11
T363A No 1 1 2 2 (1h)
T394A No 1 1 2 6 1
T403A Yes 1 1 2 2 1
T435A Yes 1 1 2 1 2
T463A No 1 1 1 1 2
S473A Yes 1 1 2 1 2
a NS1 functions as determined by various assays are graded “2” for
o detectable activity, “1” for activity measured, “11” exceeding wild-
ype activity.
b Original residue identified as an in vivo phosphorylation after vaccinia
virus expression (mimicking the replicative phase of MVM infection).
c Nuclear translocation.
d Oligomerization.
e In vitro replication and resolution.
f Transactivation of the capsid gene promoter.
g Induction of cell rounding-up and detachment.
h Particular cellular alterations observed.were found to accumulate in late S-phase upon induction
(Op De Beeck and Caillet-Fauquet, 1997). Moreover, theinduction of NS1 in such cell lines led to morphological
alterations, such as cytoplasmic extensions and round-
ing-up (Caillet-Fauquet et al., 1990; Mousset et al., 1994),
similar to those described in the present work. Interest-
ingly, the thereby reported impairment or incompetence
of some NS1 phosphorylation mutants for the induction
of these alterations argues for the regulation of the re-
sponsible NS1 function(s) through phosphorylation. It is
worth noting in this respect that the cytotoxicity of NS1 in
the above-mentioned cell lines proved to depend on the
physiological state of the target cells, being exacerbated
upon cell transformation with various oncogenes (Mous-
set et al., 1994). The demonstrated involvement of protein
kinases in the signaling pathways associated with neo-
plastic transformation (Mishak et al., 1993) and the hy-
pophosphorylation of several nontoxic NS1 mutants un-
der in vivo conditions strongly suggest that NS1 cytotox-
icity is, at least in part, a regulated phenomenon
responding to the host physiology through NS1 post-
translational modifications.
The mechanism by which NS1 induces changes in the
cell morphology is currently a matter of speculation. The
analyses of nontoxic NS1 mutants for their known bio-
chemical activities have not yet allowed the correlation
of these cell disturbances with distinct NS1 activities
besides oligomerization (see Table 1). The NS1:T463A
mutant proved to be competent for all NS1 activities
under investigation (nuclear translocation, oligomeriza-
tion, viral DNA replication, P38 trans activation), yet its
failure to induce the characteristic cell rounding-up and
detachment indicates the requirement for an additional
NS1 function(s). Conversely, the replicative and trans
activating functions of NS1 do not appear to be essential
to the morphological alterations of target cells, which
can indeed be achieved by mutants (T394A, T403A) de-
ficient in both functions. Altogether, these data argue for
a component of NS1 cytotoxicity being executed by the
viral product independent of its other functions. It should
be stated that the three nontoxic NS1 mutants identified
in the present work all map within a 40-amino-acid re-
gion, raising the possibility that the cell disturbances
observed may involve the interaction of a distinct NS1
domain with a cellular target protein(s).
Prior attempts to modify NS1 by site-directed mu-
tagenesis led to the generation of polypeptides that
were severely impaired at the functional level (Li and
Rhode, 1990; Skiadopoulos and Faust, 1993; Nu¨esch et
al., 1995). This is most likely due to the choice of target
NS1 motifs that are required for multiple functions,
such as the NTP-binding site (Li and Rhode, 1990;
Nu¨esch et al., 1992), or are shared by overlapping
domains, such as the active-site tyrosine, NLS, and
site-specific DNA-binding region (Nu¨esch and Tatter-
sall, 1993; Nu¨esch et al., 1995; Mouw and Pintel, 1998).
A more suitable modulation of NS1 could be achieved
using the present approach, which was focused on
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164 CORBAU ET AL.putative regulatory elements suspected of contributing
to the timely coordination of the various NS1 functions.
This study led to the identification of mutants exhibit-
ing an interesting segregation of distinct properties,
e.g., retaining the competence for replication, while
being less cytotoxic. Some of these mutants can be
expected to be useful for therapeutic applications of
parvoviruses or vector derivatives, for which it is de-
sirable to tip the balance between NS1 replication and
cytotoxic activities in favor of one or the other function.
MATERIALS AND METHODS
Viruses and cells
Recombinant vaccinia viruses were constructed using
pTM-1 (Moss et al., 1990) derived constructs as de-
cribed and the recombinant viruses were propagated in
onolayer cultures of BSC-40 or HeLa cells and purified
ver a sucrose cushion, except for the release of the
irus from cells by three cycles of freezing and thawing
nstead of sonification (Nu¨esch et al., 1992). MVMp was
ropagated in A9 cells. HeLa, BSC-40, and A9 cells were
rown as monolayers in Dulbecco’s modified Eagle’s
edium containing 5% fetal calf serum. HeLa-S3 cells
ere grown in suspension, using spinner bottles and
oklik’s medium supplemented with 5% fetal calf serum.
lasmids, mutagenesis, and reporter constructs
Wild-type and mutant forms of pTHisNS1. Plasmid
THis-NS1wt has been described previously (Nu¨esch et
al., 1995) and consists of a modification of pTM1-NS1
(Nu¨esch et al., 1992) that expresses a (His)6-TAG fol-
lowed by an enterokinase cleavage site at the N-termi-
nus of the MVM NS1 polypeptide. Mutant forms of NS1
were obtained by replacement of the EcoRI (nt 1085) to
BstEII (nt 1885) fragment of the NS1 gene by an equiva-
lent PCR fragment containing an appropriate mutation.
All PCR-derived products were verified for the correct
coding capacity by sequencing. Site-directed substitu-
tion mutagenesis was performed by chimeric PCR as
described (Nu¨esch and Tattersall, 1993) using the exter-
nal primers 59-CTAAGCGCGGCAGA-39 (rightward) and
9-GGTAGATTGGTAACCATTC-39 (leftward) together with
wo internal overlapping primers harboring the appropriate
utation. The following primer pairs were used to substi-
ute alanine (mutation in italics) for the target serine/threo-
ine: T363 (59-GCCTGACACAAGAGCCTGCAG-39 and 59-
TGCAGGCTCTTGTGTCAGGC-39), T394 (59-GACACAA-
AGCCTCTGT-39 and 59-ACAGAGGCTCTTGTGTC-39),
403A (59-GGACCAGCCAGCGCAGGCAAATC-39 and 59-
ATTTGCCTGCGCTGGCTGGTCC-39), T435A (59-TAAT-
ACTGTGCCAACAAGAAC-39 and 59-GTTCTTGTTGGCA-
AGTCATTA-39), and T463 (59-GGTCAAGCTATTCGCATT-
AT-39 and 59-GCGAATAGCTTGACCAGAGC-39). Alanine
ubstitutions for T278 and S283 were achieved by
l
Mingle PCR using the leftward primer 59-GGTAGATTG-
TAACCATTC-39 and either of the mutation harboring
rimers 59-CGGCAGAATTCAAGCTAAAAAAGAAGT-39
T278A) or (59-CGGCAGAATTCAAACTAAAAAAGAAGT-
GCTATTAAAACTACACTTAAAG-39 (S283A).
Other NS1 clones. The mutations were transferred from
THisNS1 to other NS1 clones [pRSV-NS (Spegelaere et al.,
994); pP4-NS1-P4-GFP] by exchange of the EcoRV (nt 385)
o BstEII (nt 1885) fragment of MVM DNA.
Reporter constructs. The MVM origin-containing plas-
ids pLEB711 and pREB1418 serving as substrates in in
itro replication assays have been described (Cotmore et
l., 1992, 1993). The pP38-Luc reporter used to measure
rans activation of the capsid gene promoter has been
escribed by Vanacker et al. (1996). vNS1inN10dl158, a
ecombinant vaccinia virus encoding a cytoplasmic
LAG-tagged NS1 deletion mutant used for in vivo oli-
omerization assays (Nu¨esch and Tattersall, 1993), and
P4-NS1-P4-GFP/pP4-NS1-CMV-GFP were used to mea-
ure the persistence and cytopathic effects of NS1 ex-
ression in transfected cells. To construct the latter
lones, pP4-GFP was first produced by inserting the NcoI
o XbaI fragment of pEGFP (Clontech) into NcoI- and
baI-cleaved pdbMVP (Kestler et al., 1999). The NS1-
ontaining pP4-NS1-P4-GFP derivative was then ob-
ained by insertion of the PmeI to XbaI fragment of
P4-GFP into StuI and XbaI-cleaved pdbMVP. In some
xperiments, pP4-NS1-CMV-GFP was used instead of
P4-NS1-P4-GFP, as obtained by inserting the CMV-GFP
assette in the form of a BglII fragment into BglII-cleaved
dbMVP. It should be stated that pdbMVP was deleted
or its StuI fragment (nt 2375 to 2498) in order to prohibit
he production of NS2.
n vivo 32P-labeling and tryptic peptide and phospho-
amino acid analyses
Metabolic 32P-labeling of vaccinia virus-expressed
NS1 was performed as described (Nu¨esch et al., 1998a;
Corbau et al., 1999) by coinfecting adherent HeLa cell
cultures with 15 PFU/cell of each vTF7-3 (a vaccinia virus
expressing the phage T7 RNA polymerase) and the ap-
propriate recombinant vaccinia virus containing the NS1
gene under control of the bacteriophage T7 promoter.
Labeling was performed by incubation in the presence of
[32P]orthophosphate (ICN; 10210 Ci/cell) for 4 h, starting
from 5 h postinfection. Cells were harvested directly into
RIPA buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 0.1% SDS, 1% sodium-deoxycholate, 1% Triton
X-100) containing protease and phosphatase inhibitors,
and immunoprecipitations were carried out with the NS1-
specific antiserum aSP8 (Brockhaus et al., 1996). Im-
une complexes were further purified on SDS–PAGE
nd blotted on polyvinylidene fluoride membranes (Mil-ipore), and the band corresponding to NS1 was excised.
embrane-bound NS1 was digested with 50 units of
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165MUTAGENESIS OF MVM NS1 PKC PHOSPHORYLATION SITEStrypsin (Promega) for 18 h at 37°C and purified 32P-
abeled peptides were analyzed by two-dimensional
lectrophoresis/chromatography on thin-layer cellulose
TLC) plates (Nu¨esch et al., 1998a). Phospho-amino acid
nalyses from individual phosphopeptides were per-
ormed as described for full-length NS1 by Corbau et al.
1999). Phosphopeptides were scraped off TLC plates
ydrolyzed in 6 M HCl at 110°C for 1 h, and the products
ere analyzed on TLC plates by electrophoresis in two
imensions using pH 1.9 and pH 3.5 buffer followed by
utoradiography. The positions of phosphoserine, phos-
hothreonine, and phosphotyrosine residues were mon-
tored by loading 1 mg each of the unlabeled purified
amino acids together with the 32P-labeled digests and
subsequent detection by ninhydrin reaction.
Production and purification of wild-type and mutant NS1
NS1 was produced from recombinant vaccinia viruses in
suspension cultures of HeLa-S3 cells (Nu¨esch et al., 1998a)
using 15 PFU/cell each of vTF7-3 (Fuerst et al., 1986) to-
gether with the appropriate recombinant vaccinia viruses
containing the NS1 gene under control of the bacterio-
phage T7 promoter (Nu¨esch et al., 1992, 1995). Infected
cultures were harvested 18 h postinfection, nuclear extracts
were prepared, and His-NS1 was purified using Ni21-NTA
garose (Qiagen) columns (Nu¨esch et al., 1995). NS1 prep-
rations were analyzed by discontinuous SDS–PAGE, and
roteins were detected by Coomassie blue staining. All
utant NS1 proteins that have been characterized previ-
usly were tested for their biochemical properties in vari-
us assays before being used as controls.
n vitro resolution and replication reactions with
lasmids containing MVM origins
Resolution and replication reactions were performed
s previously described (Cotmore et al., 1992, 1993) us-
ng pLEB711 and pREB1412 as substrates containing the
ight-end and left-end origins of MVM replication, re-
pectively. HeLa replication extracts were supplied with
pproximately 100 ng of purified NS1 that had been
xpressed from HeLa cells. The reaction mixture was
ncubated for 2 h at 37°C in the presence of dNTPs
ncluding [a-32P]dATP, ATP, and an ATP-regenerating sys-
em. The NS1-attached labeled products were recovered
y immunoprecipitations with aNSN (Cotmore and Tat-
tersall, 1986) and digested with ScaI, and the resulting
fragments were further separated into NS1-bound and
NS1-free fractions by centrifugation. The 32P-labeled
NA was then analyzed by 0.8% agarose gel electro-
horesis and revealed by autoradiography.
38 trans activation
To measure the ability of wild-type NS1 and mutant
5erivatives to trans activate the P38 promoter, 2 3 10 A9
cells grown in monolayer cultures were cotransfected Nwith 50 ng of the reporter plasmid pP38-Luc and various
amounts of the NS1 expression plasmid pRSV-NS1x. At
48 h posttransfection, cells were harvested into lysis
buffer (1.5 mM glyc-glycine, pH 7.8; 15 mM MgSO4, 0.4
M EGTA, 1 mM DTT, 1% Triton X-100, 10% glycerol) and
ested for luciferase activity as described (Vanacker et
l., 1996). Luciferase activities achieved by NS1 mutants
ere expressed as percentages of the value obtained
ith wild-type NS1, after subtraction of the background
easured in the absence of any expression vector.
ntracellular localization of NS1 by indirect
mmunofluorescence
For determination of the subcellular localization of
S1, A9 cells were grown on spot slides, infected with
he recombinant vaccinia viruses vTF7-3 and vHisNS1x
(15 PFU/cell each), fixed with paraformaldehyde 5 h
postinfection, and immunostained for NS1 protein ex-
pression using aNS1c antiserum and FITC-conjugated
anti-rabbit IgG (Cotmore and Tattersall, 1988). For detec-
tion of NS1 in the presence of GFP, cells were fixed in
paraformaldehyde (25 min), followed by neutralization in
50 mM NH4Cl (6 min), permeabilization with 0.2% Triton
X-100 (2 min), and a second fixation in paraformaldehyde
(10 min) to avoid the loss of GFP. Oligomerization of a
given NS1 product was determined by measuring its
capacity for cotransporting the cytoplasmic NS1:
inN10dl158 mutant into the nucleus (Nu¨esch and Tatter-
sall, 1993). A9 cells grown on spot slides were infected
with 15 PFU/cell of each of the recombinant vaccinia
viruses vTF7-3, vNS1Nuc, and vNS1inN10dl158, producing
7 RNA polymerase required for NS1 expression, wild-
ype or mutant nuclear NS1 to be assayed for transport,
nd cytoplasmic reporter NS1, respectively. Infected cells
ere fixed with paraformaldehyde 11 h postinfection and
S1 proteins were detected by double-immunofluores-
ence. The cytoplasmic deletion mutant NS1:inN10dl158
as specifically revealed with a 1:100 dilution of mouse
aM2 monoclonal antibodies (Sigma), due to an N-termi-
nal FLAG-epitope (inN10) and stained using FITC-conju-
gated anti-mouse secondary antibodies. Full-length NS1
polypeptides (wild type and phosphorylation-site mu-
tants) were recognized specifically by means of a 1:100
dilution of aNS1NLS, a rabbit antiserum raised against a
peptide that corresponds to amino acids 101 to 213 of
NS1 (Cotmore and Tattersall, 1986) and is located within
the region deleted from dl158. Bound aNS1NLS antibodies
were detected with Texas red-conjugated anti-rabbit sec-
ondary antibodies.
Determination of morphological changes induced by
NS1
A9 cells grown on spot slides were transfected with
200 ng per spot of pP4-NS1x-P4-GFP, pP4-GFP, or pP4-
S1,x-CMV-GFP, using 1 ml of lipofectamine (Gibco BRL)
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166 CORBAU ET AL.in the presence of OPTI-MEM. At 5 h posttransfection,
the medium was changed to DMEM containing 10% FCS,
and living cells expressing GFP were monitored for mor-
phological changes at 24-h intervals.
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